Latest News about BIIB
Recent news which mentions BIIB
Here's Why Biotech Deals Are All the Rage Right Now
December 05, 2020
From Motley Fool
The Top 3 Contrarian Stocks to Buy Right Now
December 03, 2020
From Motley Fool
A Look Into Healthcare Sector Value Stocks
November 30, 2020
From Benzinga
5 Value Stocks To Watch In The Healthcare Sector
November 23, 2020
From Benzinga
3 Best Pharma Stocks to Buy Right Now
November 22, 2020
From Motley Fool
2 Bargain Stocks You Can Buy Right Now
November 19, 2020
From Motley Fool
3 Best Biotech Stocks to Buy in November
November 18, 2020
From Motley Fool
The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets
November 15, 2020
From Benzinga
These are the value stocks that top-performing investment newsletters like the most
November 13, 2020
From MarketWatch
Benzinga's Top Upgrades, Downgrades For November 10, 2020
November 10, 2020
From Benzinga
From Benzinga
100 Biggest Movers From Yesterday
November 10, 2020
From Benzinga
74 Stocks Moving In Monday's Mid-Day Session
November 09, 2020
From Benzinga
Why This Biogen Analyst Says The FDA Could Still Approve Aducanumab
November 09, 2020
Tickers
BIIB
From Benzinga
Benzinga's Top Upgrades, Downgrades For November 9, 2020
November 09, 2020
From Benzinga
Analysts Predict Volatility In Biogen Shares Until March 2021
November 09, 2020
From Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
November 08, 2020
From Benzinga
Barron's Picks And Pans: Apollo Global, Biogen, Biden Picks And More
November 08, 2020
From Benzinga
Biogen's Aducanumab Fails To Win FDA Panel Backing
November 06, 2020
From Benzinga
The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold
November 06, 2020
From Benzinga
Biogen Analysts Brace For Favorable Aducanumab Adcom Verdict
November 05, 2020
Tickers
BIIB
From Benzinga
Investors Cheer Gridlock Potential That Could Prevent Tax, Tech, Health Care Overhauls
November 05, 2020
From Benzinga
Signs point to FDA approval for Biogen’s experimental Alzheimer’s disease treatment, though there are skeptics
November 05, 2020
From MarketWatch
Benzinga's Top Upgrades, Downgrades For November 5, 2020
November 05, 2020
From Benzinga
10 Biggest Price Target Changes For Thursday
November 05, 2020
From Benzinga
From Benzinga
51 Biggest Movers From Yesterday
November 05, 2020
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.